BioStock Studio: Alligator’s new CSO and CMO strengthen pipeline development
Biotech company Alligator Bioscience is developing tumour-directed immunotherapies with two of their projects soon in clinical phase II. Recently, the company announced two new additions to their management team, Peter Ellmark as CSO and Christina Reimer as CMO. They both visited BioStock’s studio at Medicon Village in Lund to talk about their new roles, ongoing.